Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Invested Capital (2023 - 2025)

Nuvation Bio (NUVB) has disclosed Invested Capital for 3 consecutive years, with $352.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 24.92% to $352.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $352.9 million, a 24.92% decrease, with the full-year FY2025 number at $352.9 million, down 24.92% from a year prior.
  • Invested Capital was $352.9 million for Q4 2025 at Nuvation Bio, up from $331.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $641.1 million in Q1 2023 to a low of $268.8 million in Q2 2024.
  • A 3-year average of $484.5 million and a median of $490.6 million in 2024 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: plummeted 56.96% in 2024, then soared 40.79% in 2025.
  • Nuvation Bio's Invested Capital stood at $605.1 million in 2023, then decreased by 22.32% to $470.1 million in 2024, then fell by 24.92% to $352.9 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Invested Capital are $352.9 million (Q4 2025), $331.5 million (Q3 2025), and $378.5 million (Q2 2025).